Kimberly-Clark on Monday said it is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, combining the Huggies manufacturer with the owner of Aveeno and Band-Aid.

Kenvue shareholders will receive $3.50 per share in cash and 0.14625 Kimberly-Clark shares for each Kenvue share held at closing. That amounts to $21.01 per share, based on the closing price of Kimberly-Clark shares on Friday.

Kimberly-Clark shareholders are expected to own about 54% of the combined company. Kenvue shareholders will own about 46%.

The combination merges two businesses that own major consumer health brands, ranging from Kimberly-Clark's Kleenex and Scott lines to Kenvue's Johnson's and Neutrogena.

Recently, Kenvue's Tylenol has drawn headlines after President Trump announced th

See Full Page